INSUBCONTINENT EXCLUSIVE:
Prashant Warier, Co-founder and CEO of Qure.ai
JPG3 min read Last Updated : Sep 25 2024 | 11:46 PM IST
Qure.ai, an AI-led healthtech company, said that it has completed a $65 million
Series D funding round.
The investment will expedite expansion into the US market and other geographies, increase investment into
foundational AI models and enable complementary med-tech company acquisitions.
The Series D round saw the participation of new strategic
investors also participated in the round, including Novo Holdings, Health Quad, and TeamFund.
Founded in 2016, Mumbai-headquartered Qure
is on a mission to make healthcare more accessible and equitable globally
This has driven its AI solution development
Our work is helping to unlock clinical efficiencies and drive up the standard of care delivered to patients in the focus areas of TB, lung
imaging reporting backlogs and low screening uptakes to workforce resource constraints, not just in western societies like the US and
Lightspeed, said with diagnostic specificity and sensitivity at levels rivalling radiologists and physicians, Qure is making quality
has the potential for massive impact
In high mortality diseases like lung cancer, by enabling early diagnosis and treatment, Qure can be transformational in improving clinical
